Deaconess reports a 53% spike in flu cases and a 13% rise in RSV. A local doctor breaks down who's most at risk and what to do if you get sick.
Moderna announced the change Wednesday, about a week after revealing that the FDA’s vaccine chief was refusing to review the ...
During the COVID-19 pandemic, President Donald Trump then described mRNA technology as a "modern-day miracle." HealthDay News — In a major blow to vaccine development, the US Food and Drug ...
Ana Santos Rutschman does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations ...
WASHINGTON—In an hour-long meeting in January, Food and Drug Administration career staff laid out their objections to a plan to block a new flu shot from vaccine maker Moderna. They argued that ...
An unnamed FDA official also told reporters that it would be good for Moderna to “show some humility” and admit that it didn’t follow the regulator’s recommendations in testing its mRNA flu vaccine.
Correction: This story was updated to clarify a statement given by Department of Health and Human Services spokesperson Andrew Nixon. Moderna said on Tuesday that the Food and Drug Administration (FDA ...
After the FDA's surprise refusal to take up a review of Moderna's next-gen flu vaccine, the public disagreement between U.S. regulators and the mRNA specialist took a new turn Wednesday, with the U.S.
Moderna’s messenger RNA influenza vaccine succeeded in two pivotal clinical trials, but the Food and Drug Administration is refusing to even review the application seeking regulatory approval, telling ...
The U.S. Food and Drug Administration is refusing to consider Moderna’s application for a new flu vaccine made with Nobel Prize-winning mRNA technology, the company announced Tuesday. The news is the ...
Moderna (MRNA) Tuesday said that the U.S. Food and Drug Administration will not initiate a review of the biologics license application for its investigational influenza vaccine, mRNA-1010, and has ...
CHICAGO — Lawyers for the Chicago woman shot by a Border Patrol agent took the first steps Wednesday in filing a federal lawsuit. Maramar Martinez alongside her lawyers held a news conference ...